Cartel Digest
Drawing on our vast deal and case experience, Shearman & Sterling has developed this Resources page, which provides a wide array of substantive and practical information on our antitrust and competition practice. Please review some of the informative materials we regularly publish as a value-added service to our clients, as well as information on upcoming events and details of recent activities and newsworthy items.
Shearman & Sterling advised Investcorp on the launch of a joint venture with Aberdeen Standard Investments that will invest in infrastructure projects in Gulf Cooperation Council countries. They plan to raise between $800 million and $1 billion.
Shearman & Sterling advised the Cyprus Cooperative Bank on the sale of certain assets and liabilities to Hellenic Bank. The transaction involved the acquisition of around €10.3 billion of assets.
The American Lawyer selected CVS Health’s $70 billion acquisition of Aetna, in which Shearman & Sterling acted as legal advisor to CVS Health, as the M&A Deal of the Year. It also named the firm to its A-List, identifying the firm as one of the top-20 law firms in the United States.
Partner Ben Gris (Washington, D.C.- Antitrust) will be a panelist in a teleconference hosted by the ABA’s Mergers and Acquisitions Committee called “Alive or Dead? - Common Ownership, Coordinated Effects, and Behavioral Remedies.”
Partner Jessica Delbaum (New York-Antitrust) will moderate the panel “Antitrust: “Oh No! We Got Nailed” – Compliance After the Worst Case Scenario” at the 8th Annual Antitrust Law Leaders Forum organized by Global Competition Review (GCR) in Miami on February 1-2, 2019.
Associate Mark Weiss (Antitrust-Washington, DC), writing for the American Bar Association’s Cartel & Joint Conduct Review Winter 2019 edition, analyzes the Seventh Circuit Court of Appeals decision to affirm a lower court’s dismissal of a putative class action by indirect purchaser plaintiffs alleging that seven U.S. steel producers conspired to fix prices on the sale of steel products in the United States.
On Thursday, 7th February, the Judiciary Committee of the U.S. House of Representatives approved the No Producing and Exporting Cartels Act 2019 (NOPEC), potentially setting up a vote by the full House. NOPEC was followed by similar bill, introduced in the Senate by Republican Senator Chuck Grassley (who is a strong supporter of the U.S. ethanol and biofuel industries). This bill has picked up support from senators in both parties.
Partner Geert Goeteyn (Brussels-Antitrust) has co-authored the article “The Italian Unilever Judgment on Exclusive Dealing: Helpful Clarification or Misguided Limitation of the Court of Justice’s Intel Ruling?”